Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Cwm LLC

Cwm LLC lowered its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report) by 8.6% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 19,207 shares of the company’s stock after selling 1,810 shares during the period. Cwm LLC’s holdings in Prestige Consumer Healthcare were worth $1,176,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Provence Wealth Management Group acquired a new position in shares of Prestige Consumer Healthcare in the third quarter valued at approximately $26,000. Pacer Advisors Inc. grew its holdings in shares of Prestige Consumer Healthcare by 85.7% in the fourth quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock valued at $27,000 after purchasing an additional 204 shares in the last quarter. ORG Partners LLC acquired a new position in shares of Prestige Consumer Healthcare in the fourth quarter valued at approximately $36,000. International Assets Investment Management LLC grew its holdings in shares of Prestige Consumer Healthcare by 1,900.0% in the fourth quarter. International Assets Investment Management LLC now owns 980 shares of the company’s stock valued at $60,000 after purchasing an additional 931 shares in the last quarter. Finally, Dfpg Investments LLC grew its holdings in shares of Prestige Consumer Healthcare by 11.7% in the fourth quarter. Dfpg Investments LLC now owns 4,273 shares of the company’s stock valued at $258,000 after purchasing an additional 447 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on the stock. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, February 10th. TheStreet upgraded shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a report on Monday, February 12th. One equities research analyst has rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Prestige Consumer Healthcare currently has an average rating of “Moderate Buy” and an average target price of $110.00.

Get Our Latest Report on Prestige Consumer Healthcare

Prestige Consumer Healthcare Stock Performance

NYSE PBH opened at $70.47 on Friday. The company has a current ratio of 3.09, a quick ratio of 1.92 and a debt-to-equity ratio of 0.75. Prestige Consumer Healthcare Inc. has a 52 week low of $55.96 and a 52 week high of $75.31. The firm has a 50 day moving average of $70.93 and a two-hundred day moving average of $64.24.

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) last issued its quarterly earnings data on Thursday, February 8th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $1.04 by $0.02. The business had revenue of $282.74 million during the quarter, compared to the consensus estimate of $280.25 million. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. The company’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.04 EPS. Sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current fiscal year.

Insider Transactions at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 5,336 shares of the business’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $69.00, for a total transaction of $368,184.00. Following the completion of the sale, the senior vice president now owns 15,934 shares in the company, valued at approximately $1,099,446. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Profile

(Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Featured Stories

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.